NasdaqGM - Delayed Quote USD
Castle Biosciences, Inc. (CSTL)
16.78
-0.42
(-2.47%)
At close: May 9 at 4:00:01 PM EDT
17.25
+0.47
+(2.77%)
Pre-Market: 8:00:00 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
65,665
64,866
-5,626
-41,655
-18,983
Investing Cash Flow
-52,867
-50,137
-16,183
-166,545
-66,657
Financing Cash Flow
-6,058
6,139
-2,298
1,515
5,421
End Cash Position
89,689
119,709
98,841
122,948
329,633
Income Tax Paid Supplemental Data
--
2,503
198
120
16
Interest Paid Supplemental Data
--
434
11
16
1
Capital Expenditure
-23,914
-28,326
-13,621
-5,632
-3,483
Issuance of Capital Stock
--
--
--
--
0
Issuance of Debt
0
10,000
0
0
--
Repayment of Debt
-87
-97
-142
-122
-8
Free Cash Flow
41,751
36,540
-19,247
-47,287
-22,466
12/31/2021 - 7/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VCYT Veracyte, Inc.
29.71
-4.81%
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
CDNA CareDx, Inc
15.36
-0.19%
TWST Twist Bioscience Corporation
30.82
-5.49%
PSNL Personalis, Inc.
5.04
-2.33%
BDSX Biodesix, Inc.
0.3716
+6.84%
WAT Waters Corporation
344.06
-1.94%
XGN Exagen Inc.
5.71
-7.31%
FLGT Fulgent Genetics, Inc.
19.70
+6.14%
NTRA Natera, Inc.
151.95
-6.53%